Source: http://www.google.com/patents/US5137021?dq=6,654,957
Timestamp: 2017-06-26 16:26:05
Document Index: 674512841

Matched Legal Cases: ['Application No. 0', 'art 10', 'art 10', 'art 110', 'art 10', 'art 10', 'art 1', 'art 1']

Patent US5137021 - Lead current measurement circuit - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsAn apparatus for and method of measuring the current which flows through a cardiac pacing lead to artificially stimulate contractions of the myocardium. This current measurement is useful for estimating battery life and monitoring proper operation of the pacing lead and the implantable pulse generator....http://www.google.com/patents/US5137021?utm_source=gb-gplus-sharePatent US5137021 - Lead current measurement circuitAdvanced Patent SearchTry the new Google Patents, with machine-classified Google Scholar results, and Japanese and South Korean patents.Publication numberUS5137021 APublication typeGrantApplication numberUS 07/619,494Publication dateAug 11, 1992Filing dateNov 29, 1990Priority dateNov 29, 1990Fee statusLapsedPublication number07619494, 619494, US 5137021 A, US 5137021A, US-A-5137021, US5137021 A, US5137021AInventorsDavid A. Wayne, Tho HuynhOriginal AssigneeMedtronic, Inc.Export CitationBiBTeX, EndNote, RefManPatent Citations (11), Non-Patent Citations (2), Referenced by (138), Classifications (7), Legal Events (5) External Links: USPTO, USPTO Assignment, EspacenetLead current measurement circuit
US 5137021 AAbstract
An apparatus for and method of measuring the current which flows through a cardiac pacing lead to artificially stimulate contractions of the myocardium. This current measurement is useful for estimating battery life and monitoring proper operation of the pacing lead and the implantable pulse generator.
The measurement is accomplished by carefully controlling the gain of the output amplifier and timing the rate of charge and discharge of the output capacitor. The average pacing current can be determined from the relative charge and discharge times given that the other circuit component values are known and controlled.
1. A method of measuring the current within the output circuit of an artificial pacing system comprising:a. charging an output capacitor using a reference circuit to a predetermined voltage; b. discharging said output capacitor producing an artificial pacing pulse; c. determining the length of time of said artificial pacing pulse; d. further discharging said output capacitor to produce a reference current; e. measuring the time of said further discharging said output capacitor; and, f. computing said current within said output circuit of said artificial pacing system as said reference current of said further discharging multiplied by said length of time required to perform step b divided by said time of said further discharging. 2. A method according to claim wherein said predetermined voltage is a programmable parameter.
3. A method according to claim 2 wherein said time of said discharge step is a pacing pulse width.
4. An apparatus for measuring the output current of a cardiac pacer comprising:a. an output capacitor; b. a system for charging said output capacitor; c. means for discharging said output capacitor for producing an artificial pacing pulse; d. means coupled to said output capacitor and said system for determining when said output capacitor has been discharged to a predetermined voltage; e. means for measuring the time for said system to discharge said output capacitor to said predetermined voltage and, f. means coupled to said determining means and said measuring means for calculating said output current. 5. An apparatus according to claim 4 wherein said determining means further comprises means for programming said predetermined voltage.
6. An apparatus according to claim 5 further comprising means for computing current of said output capacitor during discharge.
7. An apparatus according to claim 6 wherein said computing means further comprises means for finding said output current as the charging current multiplied by said charging time divided by said discharging time.
8. In a cardiac pacing system, having a circuit for charging an output capacitor at a reference current and means for discharging said output capacitor through a pacing lead, the improvement for measuring current through said pacing lead comprising:a. means for measuring the time for said circuit to charge said output capacitor; and, b. means coupled to said measuring means for calculating said current through said pacing lead as a function of said measured time for said circuit to charge said output capacitor. 9. The improvement of claim 8 further comprising means for comparing a control voltage to the voltage of said output capacitor to determine an end to said time for said circuit to charge said output capacitor.
The present invention generally relates to implantable medical devices, and more particularly, relates to implantable cardiac pacing devices.
The medical treatment of bradycardia by artificial cardiac pacing has been known for some time. Currently, such treatment using an implantable pulse generator electrically coupled to the myocardial tissue via an insulated lead is well accepted.
Much has been done concerning efficiency of the therapy in relation to the acute and chronic condition of the pacing lead and electrode positioning. "Atrial Pacing: Efficacy and Safety" by Kerr, et al., Pace, Volume 12, July 1989, pages 1049-1054, describes a study of atrially paced patients. It is apparent from such studies that the ability to measure various lead parameters both acutely and chronically is most desirable.
Acute measurement of certain lead parameters can be accomplished using a pacing system analyzer. Typically this is an external device which is used at the time of implant to verify proper lead position and function. U.S. Pat. No. 4,141,367 issued to Ferreira describes such a pacing system analyzer which measures lead impedance as computed by measuring output capacitor voltage before and after delivery of a pacing pulse. U.S. Pat. No. 4,364,396 issued to Barthel teaches a pacing system analyzer which measures output energy by sensing output capacitor voltage before and after pacing.
Lead impedance and pulse output measurements are also made chronically by some implantable pulse generators. Normally this data is subsequently telemetered external to the patient for display and analysis. U.S. Pat. No. 4,332,256 issued to Brownlee et al., discusses an implantable pulse generator which uses change in voltage across the output capacitor to determine lead impedance. U.S. Pat. No. 4,899,750 issued to Ekwall uses a similar technique to prepare a moving average of the lead impedance value. European Patent Application No. 0 338 363 in the name of Hafelfinger et al., suggests that lead impedance measurements should be made automatically upon the occurrence of various events.
U.S. Pat. No. 4,337,776 issued to Daly et al., proposes to measure lead impedance by monitoring successive output pulses of different amplitude. U.S. Pat. No. 4,949,720 issued to Thompson measures lead current directly by monitoring the current through FET devices in parallel with the main output path.
The present invention overcomes the disadvantages of the prior art by providing a technique to measure pacing lead current indirectly without requiring precision measurement of the output pulse voltage. To accomplish this, the present invention uses an amplifier and switched capacitors to set a reference threshold accurately related to the voltage lost from the capacitor during an output pulse. Using this threshold, the lead current can be easily determined by measuring the output pulse width and the length of time required to discharge the capacitor to the threshold determined by the output amplifier.
Computing lead current by measuring output capacitor discharge time, rather than monitoring voltage drop across the output capacitor or sensing current flow in the lead circuit directly, promotes greater accuracy. In addition, this technique does not require accurate knowledge of the output capacitor value. Furthermore, because of the simplicity of the components, the circuitry is suitable for implementation in either external or implantable form.
FIG. 1 is a schematic diagram of the pacer output circuit during charging of the output capacitor;
FIG. 2 is a schematic diagram of the output circuit during a pacing pulse which causes a discharging of the output capacitor;
FIG. 3 is a schematic diagram showing how charge loss is determined;
FIG. 4 is a schematic diagram of the control logic; and,
FIG. 5 is a graphical representation of the voltage drop across the output capacitor.
FIG. 1 is a schematic diagram of the major components of the cardiac pacer output circuit. Heart 10 of the patient presents resistive load 12 having a magnitude determined by various physiological factors. Resistive load 12 also contains the resistance of lead 11. Lead 11 is shown only as an electrical conductor in this schematic diagram. It has a resistance which is small in relation to the resistance within the body. Capacitor 14 is the series blocking capacitor to prevent DC current flow in the load. This is customarily used to prevent corrosion.
Single pole, single throw switch 16 is representative of the device which enables transfer of a pacing pulse through lead 11 to heart 10. A manual switch is shown for convenience, however, in practice the switch ordinarily consists of a semiconductor circuit.
Output capacitor 18 is charged between pacing pulses by charging circuit 15 which selects the output pacing voltage amplitude, and is discharged to provide the energy for the pacing pulse. This technique is helpful in meeting battery and size constraints for implantable devices because of the low duty cycle of the actual pacing output. Oftentimes external devices without these stringent battery and size constraints use similar circuit designs. Charging of output capacitor 18 occurs whenever single pole, single throw switch 17 is closed as shown. Output capacitor 18 discharges through heart 110 via lead 11 upon closing of single pole, single throw switch 16. Return path 13 is through the patient's body to the metal case of the implantable pulse generator for unipolar systems.
As output capacitor 18 is charged, it is connected to amplifier 22 via capacitors 20 and 30. Capacitor 24 controls the response of controlled gain amplifier 22, ensuring its stability. The input and output of amplifier 22 are connected together through switch 28 during this mode. The effect of this connection is to cause the amplifier offset voltage to be present at its output and input terminals. The value of voltage across capacitors 20 and 30 is thus the difference of the voltage on capacitor 18 and the amplifier's offset voltage.
FIG. 2 is a schematic of the circuit of FIG. 1 shown during transfer of the pacing pulse to heart 10. Pacing occurs when single pole, single throw switch 16 is closed permitting output capacitor 18 to discharge through capacitor 14 and resistive load 12 of heart 10. The return path 13 is via the body for unipolar applications. Single pole, single throw switch 28 is shown in the open state. The remaining referenced elements are as previously described.
During this stage, the voltage loss on capacitor 18 is inverted (and possibly scaled) by the amplifier and capacitors 30 and 26. The resultant output is impressed on capacitor 20. At the end of the pacing output period, capacitor 20 has a voltage stored on it equal to the original voltage decreased by the sum of the output voltage drop, the scaled output voltage drop, and the amplifier offset voltage.
FIG. 3 is a schematic diagram of the output circuit of FIG. 1 showing connection of the elements which provide the timing to control the measurement of lead current. During this phase, single pole, single throw switch 16 is open.
The digital to analog converter, IDAC 34, provides a current output which may be digitally programmed using standard techniques. A fixed current source may likewise be employed. This current is set to a convenient value by the control logic. Capacitor 20 is then connected to the input of the amplifier. The amplifier is then operated as a comparator and may be modified for higher speed by opening switch 28 to remove compensation capacitor 26 from the circuit. Because of the voltage stored in capacitor 20, the comparator will change state when capacitor 18 has been further discharged by an amount proportional (through the scaling of the previous step) to the drop due to the output pulse.
Logic 32 measures the length of time required to discharge output capacitor 18 according to the voltage as impressed on capacitor 20. Similarly logic 32 measures the length of time during which output capacitor 18 discharges. Because the capacitance of output capacitor 18 is fixed, the current through the discharge circuit (i.e. termed lead current) can be determined by controlling the gain of amplifier 22 as explained above and by knowing the IDAC current and discharge time of output capacitor 18. The remaining referenced elements are as previously described.
FIG. 4 is a block diagram of the operation of logic 32. Voltage compare 36 compares the voltage drop across output capacitor 18 to the programmed control voltage output during the discharging process. Until the voltages are equal, gate 40 enables the output of clock 38 to count up in counter 42. As soon as the voltages are equal, voltage compare 36 causes gate 40 to disable pulses from clock 38 for counter 42, thus freezing the count.
Similarly, when the voltages are equal, gate 44 enables an output of counter 42 as a representation of the length of time required to recharge output capacitor 18. Counter 42 must also be cleared using circuitry not shown before the counting is reinitiated.
Register 48 is preloaded with control current output at the time of programming the implantable pulse generator. Until the voltage comparison indicates completion of the discharge, the content of register 48 is enabled by gate 46 to IDAC 34 (see also FIG. 3), setting the value of the discharge current.
FIG. 5 is a graphical representation 60 of the voltage 64 of output capacitor 18 over time 62. Note the voltage is measured as a negative quantity. Voltage 66 represents the quiescent fully charged state. Curve 68 shows the discharge as a result of the delivery of a pacing pulse. Curve 69 shows the discharge activity. Note that the baseline shifts during this interval because output capacitor 18 is discharged using the IDAC.
The pace output time 74 is relatively short compared to discharge time (i.e. count 76). However, the change of voltage 70, as a result of pace output discharging, is equal with (or perhaps scaled proportionally to) the change of voltage 72 as a result of IDAC discharging. The resulting lead current becomes the reference current from the IDAC times the ratio of the IDAC discharge time (i.e. count 76) to the pace discharge time (i.e. pace 74).
Having thus described the preferred embodiments of the present invention, those of skill in the art will readily appreciate that various other embodiments of the present invention may be made and used from the teachings found herein within the scope of the claims hereto attached.
12 resistive load
13 return path
15 circuit
16 single pole, single throw switch
18 output capacitor
22 controlled gain amplifier
28 single pole, single throw switch
30 capacitor
34 digital to analog converter IDAC
36 voltage compare
38 clock
42 counter
44 gate
60 graphical representation
62 time
74 pace output time
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS3747605 *Oct 20, 1971Jul 24, 1973Beaumont Hospital WilliamDefibillator and method and apparatus for calibrating, testing, monitoring and/or controlling a defibrillator or the likeUS3886950 *Oct 1, 1973Jun 3, 1975Spacelabs IncDefibrillatorUS4087637 *Sep 8, 1976May 2, 1978Esb IncorporatedPacer pulse width signaling system for telephonic communicationUS4141367 *Apr 29, 1977Feb 27, 1979Med Telectronics Ltd.Cardiac electrode/pacer system analyzerUS4332256 *Mar 12, 1980Jun 1, 1982Research CorporationSystem for monitoring hermetic integrity, pacing pulse and load impedance in cardiac pacersUS4337776 *Aug 29, 1980Jul 6, 1982Telectronics Pty. Ltd.Impedance measuring pacerUS4364396 *Jun 15, 1981Dec 21, 1982Medtronic, Inc.Circuit and method for measuring PSA output and energyUS4606350 *Nov 28, 1984Aug 19, 1986Telectronics N.V.Pacemaker battery impedance test circuit and method of operationUS4899750 *Apr 19, 1988Feb 13, 1990Siemens-Pacesetter, Inc.Lead impedance scanning system for pacemakersUS4949720 *Sep 20, 1988Aug 21, 1990Medtronic, Inc.Apparatus for measuring the lead current in a pacemakerEP0338363A2 *Apr 10, 1989Oct 25, 1989Pacesetter ABConfiguration programming of an implantable pacemaker* Cited by examinerNon-Patent CitationsReference1"Atrial Pacing: Efficacy and Safety", Pace, vol. 12, Jul. 1989, Part 1, pp. 1049-1054.2 *Atrial Pacing: Efficacy and Safety , Pace, vol. 12, Jul. 1989, Part 1, pp. 1049 1054.* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS5507786 *Apr 14, 1994Apr 16, 1996Pacesetter, Inc.System and method for measuring and storing parametric data pertaining to operating characteristics of an implantable medical deviceUS5549646 *Dec 6, 1994Aug 27, 1996Pacesetter, Inc.Periodic electrical lead intergrity testing system and method for implantable cardiac stimulating devicesUS5571156 *Jun 21, 1994Nov 5, 1996The United States Of America As Represented By The Department Of Health And Human ServicesSwitched implantable electrical stimulator leadsUS5897577 *Nov 7, 1997Apr 27, 1999Medtronic, Inc.Pacing lead impedance monitoring circuit and methodUS5910156 *Nov 7, 1997Jun 8, 1999Medtronic Inc.Non-physiologic sense detection for implantable medical devicesUS5925068 *Feb 6, 1998Jul 20, 1999Pacesetter, Inc.Method for determining an ICD replacment timeUS6167309 *Sep 15, 1997Dec 26, 2000Cardiac Pacemakers, Inc.Method for monitoring end of life for batteryUS6317633Jan 19, 2000Nov 13, 2001Medtronic, Inc.Implantable lead functional status monitor and methodUS6445952May 18, 2000Sep 3, 2002Medtronic, Inc.Apparatus and method for detecting micro-dislodgment of a pacing leadUS6473648Dec 6, 1999Oct 29, 2002Intermedics Inc.Implantable cardiac stimulator with electrode-tissue interface characterizationUS6564099Dec 6, 1999May 13, 2003Intermedics, Inc.Implantable cardiac stimulator with electrode-tissue interface characterizationUS6584355Apr 10, 2001Jun 24, 2003Cardiac Pacemakers, Inc.System and method for measuring battery currentUS6631293Apr 23, 2001Oct 7, 2003Cardiac Pacemakers, Inc.Method for monitoring end of life for batteryUS6654640Mar 6, 2002Nov 25, 2003Cardiac Pacemakers, Inc.Method for monitoring end of life for batteryUS6721600Dec 31, 2001Apr 13, 2004Medtronic, Inc.Implantable lead functional status monitor and methodUS6788972Feb 21, 2003Sep 7, 2004Intermedics Inc.Implantable cardiac stimulator with electrode-tissue interface characterizationUS6885894Mar 25, 2003Apr 26, 2005Cardiac Pacemakers, Inc.System and method for measuring battery currentUS6940255Oct 23, 2003Sep 6, 2005Cardiac Pacemakers, Inc.Battery charge indicator such as for an implantable medical deviceUS7027863Oct 25, 2000Apr 11, 2006Impulse Dynamics N.V.Device for cardiac therapyUS7047083Sep 30, 2002May 16, 2006Medtronic, Inc.Method and apparatus for identifying lead-related conditions using lead impedance measurementsUS7062318Oct 31, 2001Jun 13, 2006Impulse Dynamics (Israel) LtdElectrical muscle controllerUS7089057Apr 26, 2002Aug 8, 2006Medtronic, Inc.Detection of possible failure of capacitive elements in an implantable medical deviceUS7167748Jun 10, 2004Jan 23, 2007Impulse Dynamics NvElectrical muscle controllerUS7191005Feb 24, 2005Mar 13, 2007Cardiac Pacemakers, Inc.System and method for measuring battery currentUS7200441Jun 21, 2004Apr 3, 2007Cardiac Pacemakers, Inc.Implantable cardiac stimulator with electrode-tissue interface characterizationUS7239146Jul 11, 2003Jul 3, 2007Cardiac Pacemakers, Inc.Indicator of remaining energy in storage cell of implantable medical deviceUS7251527Jul 31, 2003Jul 31, 2007Cardiac Pacemakers, Inc.Method for monitoring end of life for batteryUS7460907Jul 18, 1999Dec 2, 2008Impulse Dynamics N.V.Pacing with hemodynamic enhancementUS7515962Oct 7, 2003Apr 7, 2009Cardiac Pacemakers, Inc.Method for monitoring end of life for batteryUS7567840Oct 28, 2005Jul 28, 2009Cyberonics, Inc.Lead condition assessment for an implantable medical deviceUS7580749Jul 18, 2007Aug 25, 2009Cardiac Pacemakers, Inc.Method for monitoring end of life for batteryUS7647102Nov 18, 2005Jan 12, 2010Impulse Dynamics N.V.Cardiac contractility modulation device having anti-arrhythmic capabilities and method of operating thereofUS7678573Apr 11, 2005Mar 16, 2010Pluristem Ltd.Method of preparing a conditioned medium from a confluent stromal cell cultureUS7751891Jul 28, 2004Jul 6, 2010Cyberonics, Inc.Power supply monitoring for an implantable deviceUS7769455Jan 27, 2006Aug 3, 2010Cyberonics, Inc.Power supply monitoring for an implantable deviceUS7840262Mar 10, 2004Nov 23, 2010Impulse Dynamics NvApparatus and method for delivering electrical signals to modify gene expression in cardiac tissueUS7843439Mar 26, 2007Nov 30, 2010N-Trig Ltd.Touch detection for a digitizerUS7953481Oct 25, 2000May 31, 2011Impulse Dynamics N.V.Anti-arrhythmic device and a method of delivering anti-arrhythmic cardiac therapyUS7953488Jul 31, 2008May 31, 2011Medtronic, Inc.Pre-qualification of an alternate sensing configurationUS7974690Jun 30, 2008Jul 5, 2011Medtronic, Inc.Lead integrity testing during suspected tachyarrhythmiasUS7974707Jan 26, 2007Jul 5, 2011Cyberonics, Inc.Electrode assembly with fibers for a medical deviceUS8019421Sep 5, 2002Sep 13, 2011Metacure LimitedBlood glucose level controlUS8078277Oct 29, 2008Dec 13, 2011Medtronic, Inc.Identification and remediation of oversensed cardiac events using far-field electrogramsUS8126553Jul 25, 2008Feb 28, 2012Medtronic, Inc.Sensing integrity determination based on cardiovascular pressureUS8180462Apr 18, 2006May 15, 2012Cyberonics, Inc.Heat dissipation for a lead assemblyUS8190258Jul 7, 2009May 29, 2012Cyberonics, Inc.Lead condition assessment for an implantable medical deviceUS8200322Jul 30, 2008Jun 12, 2012Medtronic, Inc.Electrogram storage for suspected non-physiological episodesUS8228311May 16, 2008Jul 24, 2012N-Trig Ltd.Touch detection for a digitizerUS8244371Mar 16, 2006Aug 14, 2012Metacure LimitedPancreas leadUS8260416Oct 31, 2007Sep 4, 2012Impulse Dynamics, N.V.Electrical muscle controllerUS8295946May 23, 2011Oct 23, 2012Cyberonics, Inc.Electrode assembly with fibers for a medical deviceUS8301247Oct 31, 2007Oct 30, 2012Impulse Dynamics, N.V.Electrical muscle controllerUS8311629Oct 18, 2006Nov 13, 2012Impulse Dynamics, N.V.Electrical muscle controllerUS8321013Oct 31, 2007Nov 27, 2012Impulse Dynamics, N.V.Electrical muscle controller and pacing with hemodynamic enhancementUS8326416Oct 25, 2010Dec 4, 2012Impulse Dynamics NvApparatus and method for delivering electrical signals to modify gene expression in cardiac tissueUS8346363Dec 27, 2005Jan 1, 2013Metacure LimitedBlood glucose level controlUS8352031May 24, 2007Jan 8, 2013Impulse Dynamics NvProtein activity modificationUS8396543Jan 28, 2010Mar 12, 2013Medtronic, Inc.Storage of data for evaluation of lead integrityUS8437840Sep 26, 2011May 7, 2013Medtronic, Inc.Episode classifier algorithmUS8463384Jan 27, 2011Jun 11, 2013Medtronic, Inc.Isolated lead conductor measurements for fault detectionUS8478420Jul 12, 2006Jul 2, 2013Cyberonics, Inc.Implantable medical device charge balance assessmentUS8478428Apr 23, 2010Jul 2, 2013Cyberonics, Inc.Helical electrode for nerve stimulationUS8483846Apr 8, 2010Jul 9, 2013Cyberonics, Inc.Multi-electrode assembly for an implantable medical deviceUS8521281Oct 14, 2011Aug 27, 2013Medtronic, Inc.Electrogram classification algorithmUS8532773May 1, 2012Sep 10, 2013Cyberonics, Inc.Lead condition assessment for an implantable medical deviceUS8548583May 4, 2006Oct 1, 2013Impulse Dynamics NvProtein activity modificationUS8560070Mar 17, 2010Oct 15, 2013Cyberonics, Inc.Power supply monitoring for an implantable deviceUS8565881Jun 22, 2010Oct 22, 2013Cyberonics, Inc.Power supply monitoring for an implantable deviceUS8577457Jul 7, 2011Nov 5, 2013Medtronics, Inc.Isolating lead body for fault detectionUS8577459Jan 28, 2011Nov 5, 2013Cyberonics, Inc.System and method for estimating battery capacityUS8644931Jul 25, 2008Feb 4, 2014Medtronic, Inc.Impedance variability analysis to identify lead-related conditionsUS8666495Mar 18, 2005Mar 4, 2014Metacure LimitedGastrointestinal methods and apparatus for use in treating disorders and controlling blood sugarUS8700161Sep 4, 2003Apr 15, 2014Metacure LimitedBlood glucose level controlUS8744560Sep 30, 2011Jun 3, 2014Medtronic, Inc.Electrogram summaryUS8751000Oct 2, 2013Jun 10, 2014Medtronic, Inc.Isolating lead body for fault detectionUS8761884Apr 14, 2011Jun 24, 2014Cyberonics, Inc.Device longevity prediction for a device having variable energy consumptionUS8761885Apr 29, 2011Jun 24, 2014Cyberonics, Inc.Battery life estimation based on voltage depletion rateUS8774909Sep 26, 2011Jul 8, 2014Medtronic, Inc.Episode classifier algorithmUS8781585Nov 21, 2011Jul 15, 2014Medtronic, Inc.Identification and remediation of oversensed cardiac events using far-field electrogramsUS8792985Jan 20, 2006Jul 29, 2014Metacure LimitedGastrointestinal methods and apparatus for use in treating disorders and controlling blood sugarUS8798751Jun 9, 2011Aug 5, 2014Medtronic, Inc.Method and apparatus to manage lead-related conditions for fault tolerance enhancementsUS8825152Apr 3, 2002Sep 2, 2014Impulse Dynamics, N.V.Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissueUS8855765Jun 9, 2011Oct 7, 2014Medtronic, Inc.Fault tolerant methods and architectures for embedded intelligence in medical leadsUS8868203Oct 26, 2007Oct 21, 2014Cyberonics, Inc.Dynamic lead condition detection for an implantable medical deviceUS8874229Apr 28, 2010Oct 28, 2014Cyberonics, Inc.Delivering scheduled and unscheduled therapy without detriment to battery life or accuracy of longevity predictionsUS8886296Oct 14, 2011Nov 11, 2014Medtronic, Inc.T-wave oversensingUS8934975Feb 1, 2011Jan 13, 2015Metacure LimitedGastrointestinal electrical therapyUS8942798Oct 26, 2007Jan 27, 2015Cyberonics, Inc.Alternative operation mode for an implantable medical device based upon lead conditionUS9037240Jul 25, 2008May 19, 2015Medtronic, Inc.Electrode lead integrity reportsUS9101765Feb 16, 2006Aug 11, 2015Metacure LimitedNon-immediate effects of therapyUS9126054May 13, 2014Sep 8, 2015Cyberonics, Inc.Device longevity prediction for a device having variable energy consumptionUS9232898Oct 18, 2012Jan 12, 2016Medtronic, Inc.Method and apparatus to manage lead-related conditions for fault tolerance enhancementsUS9242110Aug 3, 2015Jan 26, 2016Cyberonics, Inc.Device longevity prediction for a device having variable energy consumptionUS9289618Oct 23, 2001Mar 22, 2016Impulse Dynamics NvElectrical muscle controllerUS9421355Oct 15, 2014Aug 23, 2016Cyberonics, Inc.Delivering scheduled and unscheduled therapy without detriment to battery life or accuracy of longevity predictionsUS9522277Jul 28, 2008Dec 20, 2016Medtronic, Inc.Lead integrity testing triggered by sensed signal saturationUS9539428Jan 27, 2011Jan 10, 2017Medtronic, Inc.Isolating lead conductor for fault detectionUS9668668Sep 30, 2011Jun 6, 2017Medtronic, Inc.Electrogram summaryUS20020052632 *Oct 31, 2001May 2, 2002Shlomo Ben-HaimElectrical muscle controllerUS20030176897 *Mar 25, 2003Sep 18, 2003Cardiac Pacemakers, Inc.System and method for measuring battery currentUS20030204225 *Apr 26, 2002Oct 30, 2003Medtronic, Inc.Detection of possible failure of capacitive elements in an implantable medical deviceUS20040024426 *Jul 31, 2003Feb 5, 2004Cardiac Pacemakers, Inc.Method for monitoring end of life for batteryUS20040064161 *Sep 30, 2002Apr 1, 2004Gunderson Bruce D.Method and apparatus for identifying lead-related conditions using lead impedance measurementsUS20040073264 *Oct 7, 2003Apr 15, 2004Cardiac Pacemakers, Inc.Method for monitoring end of life for batteryUS20040230245 *Jun 21, 2004Nov 18, 2004Intermedics Inc.Implantable cardiac stimulator with electrode-tissue interface characterizationUS20040243190 *Jun 10, 2004Dec 2, 2004Shlomo Ben-HaimElectrical muscle controllerUS20050007073 *Jul 11, 2003Jan 13, 2005James Kristofer J.Indicator of remaining energy in storage cell of implantable medical deviceUS20050088145 *Oct 23, 2003Apr 28, 2005Robert LochBattery charge indicator such as for an implantable medical deviceUS20050143782 *Feb 24, 2005Jun 30, 2005Cardiac Pacemakers, Inc.System and method for measuring battery currentUS20060025828 *Jul 28, 2004Feb 2, 2006Armstrong Randolph KImpedance measurement for an implantable deviceUS20060025829 *Jul 28, 2004Feb 2, 2006Armstrong Randolph KPower supply monitoring for an implantable deviceUS20070100407 *Oct 28, 2005May 3, 2007Cyberonics, Inc.Lead condition assessment for an implantable medical deviceUS20070179547 *Jan 27, 2006Aug 2, 2007Cyberonics, Inc.Power supply monitoring for an implantable deviceUS20070265672 *Jul 18, 2007Nov 15, 2007Cardiac Pacemakers, Inc.Method for monitoring end of life for batteryUS20090112292 *Oct 26, 2007Apr 30, 2009Cyberonics Inc.Dynamic lead condition detection for an implantable medical deviceUS20090125079 *Oct 26, 2007May 14, 2009Cyberonics Inc.Alternative operation mode for an implantable medical device based upon lead conditionUS20090270959 *Jul 7, 2009Oct 29, 2009Cyberonics Inc.Lead condition assessment for an implantable medical deviceUS20090299201 *Jul 25, 2008Dec 3, 2009Medtronic, Inc.Electrode lead integrity reportsUS20090299421 *Jul 24, 2008Dec 3, 2009Medtronic, Inc.Evaluation of implantable medical device sensing integrity based on evoked signalsUS20090299422 *Jul 30, 2008Dec 3, 2009Medtronic, Inc.Electrogram storage for suspected non-physiological episodesUS20090299429 *Jul 25, 2008Dec 3, 2009Medtronic, Inc.Sensing integrity determination based on cardiovascular pressureUS20090299432 *Jul 25, 2008Dec 3, 2009Metronic, Inc.Impedance variability analysis to identify lead-related conditionsUS20090326600 *Jun 30, 2008Dec 31, 2009Medtronic, Inc.Lead integrity testing during suspected tachyarrhythmiasUS20100030289 *Jul 31, 2008Feb 4, 2010Medtronic, Inc.Pre-qualification of an alternate sensing configurationUS20100106209 *Oct 29, 2008Apr 29, 2010Medtronic, Inc.Identification and remediation of oversensed cardiac events using far-field electrogramsUS20100198313 *Mar 17, 2010Aug 5, 2010Cyberonics, Inc.Power supply monitoring for an implantable deviceUS20100268495 *Jun 22, 2010Oct 21, 2010Cyberonics, Inc.Power supply monitoring for an implantable deviceUS20110184481 *Jan 28, 2010Jul 28, 2011Medtronic, Inc.Storage of data for evaluation of lead integrityEP0589610A2 *Sep 15, 1993Mar 30, 1994Pacesetter, Inc.Method and apparatus for capacitor tolerance compensation in a cardiac stimulating deviceEP0589610A3 *Sep 15, 1993Dec 3, 1997Pacesetter, Inc.Method and apparatus for capacitor tolerance compensation in a cardiac stimulating deviceEP0647455A1 *Oct 5, 1994Apr 12, 1995Vitatron Medical B.V.Cardiac pacing system with improved end-of-life detectorWO1998019739A1 *Oct 31, 1997May 14, 1998Intermedics Inc.Pacemaker with intra-stimulus capture detectionWO1999024112A1Nov 4, 1998May 20, 1999Medtronic, Inc.Non-physiologic sense detection for implantable medical devicesWO2003090856A2 *Apr 17, 2003Nov 6, 2003Medtronic, Inc.Detection of possible failure of capacitive elements in an implantable medical deviceWO2003090856A3 *Apr 17, 2003Apr 8, 2004Medtronic IncDetection of possible failure of capacitive elements in an implantable medical deviceWO2012102873A1Jan 13, 2012Aug 2, 2012Medtronic, Inc.Isolating lead conductor for fault detectionWO2012170325A2Jun 4, 2012Dec 13, 2012Medtronic, Inc.Method and apparatus to manage lead-related conditions for fault tolerance enhancementsWO2015123483A1Feb 13, 2015Aug 20, 2015Medtronic, Inc.Lead monitoring frequency based on lead and patient characteristics* Cited by examinerClassifications U.S. Classification607/28, 607/29International ClassificationA61N1/08, A61N1/37Cooperative ClassificationA61N2001/083, A61N1/3706European ClassificationA61N1/37CLegal EventsDateCodeEventDescriptionNov 29, 1990ASAssignmentOwner name: MEDTRONIC, INC., 7000 CENTRAL AVENUE, MINNEAPOLIS,Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:WAYNE, DAVID A.;HUYNH, THO;REEL/FRAME:005619/0660;SIGNING DATES FROM 19901115 TO 19901127Sep 13, 1994CCCertificate of correctionMar 19, 1996REMIMaintenance fee reminder mailedAug 11, 1996LAPSLapse for failure to pay maintenance feesOct 22, 1996FPExpired due to failure to pay maintenance feeEffective date: 19960814RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services